/DISCLAIMER · RESEARCH_COMPOUND

This page is reference information only. Most compounds described here are research chemicals, not FDA-approved medications. MyTRT does not sell, recommend, or endorse the use of these substances. Always consult a qualified physician.

/9_METHYL_CARBOLINE_15MG
Peptide

9 Methyl β Carboline

Dopaminergic Nootropic Compound

/HALF_LIFE
12–16 hours (estimated)
/DELIVERY
Oral or sublingual

/WHAT_IT_IS

9-Me-BC (9-Methyl-β-carboline) is a nootropic compound with neuroprotective and dopaminergic properties, promoting the growth and survival of dopaminergic neurons.

/USAGE

Used in research targeting cognitive enhancement, neuroprotection, and dopamine-related mood support.

/MECHANISM_OF_ACTION

Promotes dopaminergic neuron differentiation and mitochondrial function, enhancing dopamine signaling and brain plasticity.

Reported Benefits

  • +Supports dopamine production
  • +Enhances motivation and mood
  • +Promotes neurogenesis
  • +Neuroprotection against oxidative stress

Reported Side Effects

  • Mild headache
  • Irritability (with excess)
  • Insomnia (if taken late)

/STACKED_WITH

CiticolineL-TheanineNSI-189

/RESEARCH_NOTES

Often cycled in nootropic stacks; low toxicity reported in preclinical studies.

/RELATED

/TRACK_THIS

Browse all 89 in the app.

MyTRT's in-app library has the same 89 peptide entries plus dosing notes, stack builders, and the ability to log them alongside your TRT protocol.

Last reviewed: 2026-06-04 · Reference only. Not medical advice. Consult a qualified physician.